NCT01252823: RYTHMODIAL

Implantable Loop Recorder in Hemodialysis Patients

Completed NA Last updated 27 November 2017

What this trial tests

NA trial testing Implantation of ILR in Hemodialysis in 72 participants. Completed in 29 February 2016.

Timeline

28 December 2010

Primary endpoint
29 February 2016

29 February 2016

Quick facts

Lead sponsor	University Hospital, Bordeaux
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	72
Start date	28 December 2010
Primary completion	29 February 2016
Estimated completion	29 February 2016
Sites	9 locations across France

Drugs / interventions tested

• Implantation of ILR

Conditions studied

• Hemodialysis — all drugs for Hemodialysis →
• Cardiac Arrhythmia — all drugs for Cardiac Arrhythmia →
• Cardiac Death — all drugs for Cardiac Death →

Sponsor

University Hospital, Bordeaux

Who can join

Adults 45 to 80, any sex, with Hemodialysis or Cardiac Arrhythmia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to use implantable loop recorder (ILR) in patients under chronic hemodialysis to record arrhythmias and conduction disorders and correlate them with hemodialysis parameters.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Cardiac Rhythm Disturbances in Hemodialysis Patients: Early Detection Using an Implantable Loop Recorder and Correlation With Biological and Dialysis Parameters.
   Sacher F, Jesel L, Borni-Duval C, De Precigout V, et al · · 2018 · cited 51× · PMID 30089568 · DOI 10.1016/j.jacep.2017.08.002